Merck

Is a VIVUS Buyout Still on the Table? And if So, by Whom?
Motley Fool
Fri, 10/12/12 - 11:02 am
Vivus
M&A
Bristol-Myers Squibb
Merck
JNJ
Arena Pharmaceuticals
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:49 am
vortioxetine
Vectura
tofacitinib
Takeda
T-DM1
Sanofi
Roche
REGN727
Regeneron
Reata
QVA149
Pfizer
Odanacatib
Novartis
MorphoSys
Merck
macitentan
Lundbeck
Immunogen
GSK
GS-7977
Gilead
gantenerumab
Eliquis
darapladib
Bristol-Myers Squibb
Biogen Idec
BG-12
Bayer
Bardoxolone
Anacetrapib
Alpharadin
Algeta
Actelion
AbbVie
Merck's Entry Into The Parkinson's Disease Drug Race
Seeking Alpha
Thu, 10/11/12 - 09:21 am
Merck
Parkinson's Disease
Preladenant
Levodopa
Eli Lilly Sees A Ray Of Hope But The Stock Is Ahead Of Itself
Seeking Alpha
Wed, 10/10/12 - 11:37 am
Eli Lilly
AstraZeneca
GSK
JNJ
Merck
Pfizer
Why Merck's Earnings Are Outstanding
Motley Fool
Tue, 10/9/12 - 04:10 pm
earnings
Merck
Investing In Cervical Cancer: Merck, Glaxo, And... Inovio?
Seeking Alpha
Tue, 10/9/12 - 11:18 am
cervical cancer
Merck
GSK
Inovio
Sarepta Therapeutics
Synageva
Merck moving its global headquarters as it looks to cut expenses, consolidate properties
Yahoo/AP
Tue, 10/9/12 - 09:59 am
Merck
consolidation
Novo Nordisk Is Positioned To Profit Off Of Obesity Epidemic But Price May Be Rich
Seeking Alpha
Tue, 10/9/12 - 09:55 am
obesity
Novo Nordisk
Merck
Bristol-Myers Squibb
diabetes
Sanofi
Merck Acquires License for Experimental Skin-Patch Immunization
Bloomberg
Tue, 10/9/12 - 09:48 am
Merck
vaccines
Vaxxas
Gardasil
Nanopatch
skin patch
Pfizer Won't Get A Slap On The Wrist From The SEC
Seeking Alpha
Tue, 10/9/12 - 09:47 am
Pfizer
SEC
GSK
JNJ
Merck
Novartis
Pharma’s Diabetes War Escalates
Motley Fool
Sat, 10/6/12 - 11:54 am
diabetes
Merck
Amalin
Extending the Diabetes Dominance
Motley Fool
Sat, 10/6/12 - 11:49 am
Merck
MK-3102
Januvia
diabetes
type 2 diabetes
Vorapaxar For Patients With Previous MI And Merck's Bottom Line
Seeking Alpha
Sat, 10/6/12 - 11:46 am
Vorapaxar
Merck
myocardial infarction
Big Pharma to benefit from growth in diabetes: S&P
Marketwatch
Fri, 10/5/12 - 11:18 am
diabetes
Big Pharma
Eli Lilly
Merck
Bristol-Myers Squibb
Merck Shrugs off Patent Worries, Eyes China
Motley Fool
Thu, 10/4/12 - 10:44 am
patents
Merck
China
Simcere
Opko's 4KScore Could Generate Over $1.8 Billion Annually
Seeking Alpha
Wed, 10/3/12 - 12:34 pm
GSK
JNJ
OPKO Health
Merck
Novartis
Pfizer
Sanofi
prostate cancer
4Kscore
Merck's once-a-week diabetes drug effective in clinical study
Reuters
Wed, 10/3/12 - 11:21 am
Merck
diabetes
MK-3102
Bristol-Myers Squibb - Between Patent Deadlines And Revenue Shifts
Seeking Alpha
Wed, 10/3/12 - 10:50 am
patents
Bristol-Myers Squibb
Amylin
AstraZeneca
Novo Nordisk
Eli Lilly
Merck
Ablynx enters alliance with Merck worth up to 448 million euros
Reuters
Tue, 10/2/12 - 09:54 am
Ablynx
Merck
Merck’s HPV Vaccine Gardasil Shown Safe in Kaiser Study
Bloomberg
Mon, 10/1/12 - 09:40 pm
Merck
HPV
vaccines
Gardasil

Pages